文献速递胸部肿瘤放疗放疗物理与技术

局限性非小细胞肺癌患者立体定向体部放疗后肋骨骨折的累积风险

Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancer.
PubMed 文献 · Radiother Oncol · 2024-08-17

该研究纳入2010至2020年在丹麦欧登塞大学医院接受立体定向体部放疗(SBRT)的602例局限性非小细胞肺癌(NSCLC)患者,采用死因为竞争风险的原因别Cox模型预测肋骨骨折累积风险。19%的患者发生肋骨骨折,最终多变量模型仅含肋骨V20、V30及平均肺剂量,未纳入患者相关参数。

要点

  • 602例接受SBRT的局限性NSCLC患者中19%发生肋骨骨折。
  • 最终多变量模型仅含肋骨V20、V30和平均肺剂量。
  • 女性和男性低骨密度是肋骨骨折风险的显著预测因素。

核心结论

  • 女性和男性低骨密度是肋骨骨折风险的显著预测因素。
  • 预测局限性NSCLC患者SBRT后19%累积肋骨骨折风险的最终模型不含患者相关参数,提示剂量学参数是主要驱动因素。

研究设计与样本

  • 纳入2010至2020年在丹麦欧登塞大学医院接受SBRT的602例局限性NSCLC患者。
  • 所有患者接受45-66 Gy/3次SBRT。
  • 采用词嵌入模型在CT扫描中识别肋骨骨折。
  • 基于原因别Cox风险模型构建累积发生率函数,变量选择基于交叉验证模型似然,使用50次自助法。

主要发现

  • 19%的患者发生肋骨骨折。
  • SBRT后6至54个月肋骨骨折累积风险快速增加。
  • 单变量分析中,女性、骨密度、肋骨近最大剂量、肋骨V30和V40、大体肿瘤体积及平均肺剂量与肋骨骨折风险显著相关。
  • 最终多变量模型包含肋骨V20、V30和平均肺剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Rib fracture is a known complication after stereotactic body radiotherapy (SBRT). Patient-related parameters are essential to provide patient-tailored risk estimation, however, their impact on rib fracture is less documented compared to dosimetric parameters. This study aimed to predict the risk of rib fractures in patients with localized non-small cell lung cancer (NSCLC) post-SBRT based on both patient-related and dosimetric parameters with death as a competing risk. MATERIALS AND METHODS: In total, 602 patients with localized NSCLC treated with SBRT between 2010-2020 at Odense University Hospital, Denmark were included. All patients received SBRT with 45-66 Gray (Gy)/3 fractions. Rib fractures were identified in CT-scans using a word embedding model. The cumulative incidence function was based on cause-specific Cox hazard models with variable selection based on cross-validation model likelihood performed using 50 bootstraps. RESULTS: In total, 19 % of patients experienced a rib fracture. The cumulative risk of rib fracture increased rapidly from 6-54 months post-SBRT. Female gender, bone density, near max dose to the rib, V30 and V40 to the rib, gross tumor volume, and mean lung dose were significantly associated with rib fracture risk in univariable analysis. The final multi-variable model consisted of V20 and V30 to the rib and mean lung dose. CONCLUSION: Female gender and low bone density in male patients are significant predictors of rib fracture risk. The final model predicting cumulative rib fracture risk of 19 % in patients with localized NSCLC treated with SBRT contained no patient-related parameters, suggesting that dosimetric parameters are the primary drivers.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Bentsen KK, Brink C, Nielsen TB, et al. Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancer. Radiother Oncol. 2024. PMID: 39159679. doi:10.1016/j.radonc.2024.110481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。